Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Slack

Showing results (151-160 of 472) with videos related to

Pageof 48
Sort By:
Aging|September 23, 2011
Longevity and stress in Caenorhabditis elegansKatherine I Zhou, Zachary Pincus, Frank J Slack
Advances in Experimental Medicine and Biology|January 1, 1980
Family study of lipid and purine levels in gout patients and analysis of mortalityL G Darlington, J Slack, J T Scott
Cancers|September 10, 2021
Photodynamic Therapy for Pancreatic Ductal AdenocarcinomaVida Karimnia, Frank J Slack, Jonathan P Celli
Annals of the Rheumatic Diseases|June 1, 1983
Vascular mortality in patients with gout and in their familiesL G Darlington, J Slack, J T Scott
International Journal of Molecular Sciences|July 19, 2018
The Nefarious Nexus of Noncoding RNAs in CancerEleni Anastasiadou, Alberto Faggioni, Pankaj Trivedi, et al.
Current Biology : CB|August 20, 2014
Aberrant regulation and function of microRNAs in cancerBrian D Adams, Andrea L Kasinski, Frank J Slack
Cancer Research|June 22, 2016
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in CancerAlexander A Svoronos, Donald M Engelman, Frank J Slack
Developmental Biology|July 23, 2003
The time of appearance of the C. elegans let-7 microRNA is transcriptionally controlled utilizing a temporal regulatory element in its promoterSteven M Johnson, Shin Yi Lin, Frank J Slack
European Journal of Pharmacology|November 4, 2018
Pharmacological characterisation of a tool αvβ1 integrin small molecule RGD-mimetic inhibitorAlex L Wilkinson, John W Barrett, Robert J Slack
SLAS Discovery : Advancing Life Sciences R & D|April 18, 2017
Determining the True Selectivity Profile of αv Integrin Ligands Using Radioligand Binding: Applying an Old Solution to a New ProblemJames E Rowedder, Steve B Ludbrook, Robert J Slack
Pageof 48

Showing results (151-160 of 472) with videos related to

Sort By:
Pageof 48
Aging|September 23, 2011
Longevity and stress in Caenorhabditis elegansKatherine I Zhou, Zachary Pincus, Frank J Slack
Advances in Experimental Medicine and Biology|January 1, 1980
Family study of lipid and purine levels in gout patients and analysis of mortalityL G Darlington, J Slack, J T Scott
Cancers|September 10, 2021
Photodynamic Therapy for Pancreatic Ductal AdenocarcinomaVida Karimnia, Frank J Slack, Jonathan P Celli
Annals of the Rheumatic Diseases|June 1, 1983
Vascular mortality in patients with gout and in their familiesL G Darlington, J Slack, J T Scott
International Journal of Molecular Sciences|July 19, 2018
The Nefarious Nexus of Noncoding RNAs in CancerEleni Anastasiadou, Alberto Faggioni, Pankaj Trivedi, et al.
Current Biology : CB|August 20, 2014
Aberrant regulation and function of microRNAs in cancerBrian D Adams, Andrea L Kasinski, Frank J Slack
Cancer Research|June 22, 2016
OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in CancerAlexander A Svoronos, Donald M Engelman, Frank J Slack
Developmental Biology|July 23, 2003
The time of appearance of the C. elegans let-7 microRNA is transcriptionally controlled utilizing a temporal regulatory element in its promoterSteven M Johnson, Shin Yi Lin, Frank J Slack
European Journal of Pharmacology|November 4, 2018
Pharmacological characterisation of a tool αvβ1 integrin small molecule RGD-mimetic inhibitorAlex L Wilkinson, John W Barrett, Robert J Slack
SLAS Discovery : Advancing Life Sciences R & D|April 18, 2017
Determining the True Selectivity Profile of αv Integrin Ligands Using Radioligand Binding: Applying an Old Solution to a New ProblemJames E Rowedder, Steve B Ludbrook, Robert J Slack
Pageof 48